Diagnostic Workup, Treatment Patterns, and Clinical Outcomes in Early-Stage IB–IIIA Non-Small-Cell Lung Cancer Patients in Denmark
EM Uldbjerg, L Ringgaard, KK Andersen… - Cancers, 2023 - mdpi.com
Simple Summary This real-world evidence study contributes important insights for clinicians
to further optimize treatment options and improve clinical outcomes in patients with early …
to further optimize treatment options and improve clinical outcomes in patients with early …
[HTML][HTML] Predictors of disease recurrence after radical resection and adjuvant chemotherapy in patients with stage IIb-IIIa squamous cell lung cancer: A retrospective …
MA Senchukova, EA Kalinin… - World Journal of …, 2024 - ncbi.nlm.nih.gov
BACKGROUND Lung cancer (LC) is a global medical, social and economic problem and is
one of the most common cancers and the leading cause of mortality from malignant …
one of the most common cancers and the leading cause of mortality from malignant …
[HTML][HTML] Real-World Clinical Outcomes of Neoadjuvant Platinum-Based Chemotherapy with Nivolumab in Non-Small Cell Lung Cancer
W Shalata, S Daher, N Maimon Rabinovitch… - Journal of Clinical …, 2024 - mdpi.com
Background: Lung cancer is among the most prevalent and serious forms of cancer,
characterized by an allogenic phenotype that presents significant therapeutic challenges …
characterized by an allogenic phenotype that presents significant therapeutic challenges …
Impact of recurrence on employment, finances, and productivity for early-stage cancer patients and caregivers: US survey
R Aguiar-Ibáñez, K McQuarrie, S Jayade… - Future …, 2024 - Taylor & Francis
Background Following an early-stage cancer diagnosis, recurrences can occur. To quantify
financial impacts of a first recurrence, we surveyed patients and caregivers. Methods The …
financial impacts of a first recurrence, we surveyed patients and caregivers. Methods The …